Filing Details
- Accession Number:
- 0000908662-14-000105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-03 19:27:45
- Reporting Period:
- 2014-02-27
- Filing Date:
- 2014-03-03
- Accepted Time:
- 2014-03-03 19:27:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 907562 | Dyax Corp | DYAX | Services-Commercial Physical & Biological Research (8731) | 043053198 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1573163 | D. Andrew Ashe | C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756 | General Counsel & Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-27 | 24,000 | $10.20 | 36,277 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2014-03-03 | 30,000 | $1.48 | 66,277 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-03 | 30,000 | $10.00 | 36,277 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2014-02-27 | 144,000 | $0.00 | 144,000 | $10.20 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-03-03 | 30,000 | $0.00 | 30,000 | $1.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 144,000 | 2024-02-27 | No | 4 | A | Direct | |
| 67,500 | 2022-02-24 | No | 4 | M | Direct |
Footnotes
- The securities reported were granted pursuant to the Issuer's Amended and Restated 1995 Equity Incentive Plan. The award vests in four equal annual installments beginning on March 5, 2015.
- Such option will become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equivalent is accumulated).
- Such option vests in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, which was February 24, 2012.
Billionaire Hedge Funds
